Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Comment by Dividendspayon Dec 03, 2019 8:45am
250 Views
Post# 30416451

RE:RE:RE:RE:Australia and EU

RE:RE:RE:RE:Australia and EU
Hi Frznth,
I have had some experience, mostly because they have spent a lot of time reviewing results of submissions, which are publicly available but you do get an understanding of how they make their decisions.
 
So, my thoughts only, and I have no affiliation with any of these regulatory bodies just to be clear.
 
So to your points/questions:
 
" It wasn't clear why subjects were improving. " 
 
I had a long back-and-forth  with Prokiev and a few others about a year ago on this and I will not repeat it.  Strictly speaking, there was no true evidence of efficacy, based on the sham treatment.
Notwithstanding that  you can show an improvement, using an evidence-based approach, can see that that was simply a placebo effect, and effects will be judged as nominal,
.
I am not saying there was not an effect, I am just saying how evidence is interpreted according to current guidelines.
 
There is a lot of emotional investment here with people, and logic did not seem to make sense then, and maynot now , but that is just the way it is.
 
"But if the new study shows that patients can't make the gains they are making from physical therapy alone, how can the FDA not approve? "
 
If they can show, using pre-specified endpoints, using accepted statistical methodology, that this is the case, then yes you can make the case that there is efficacy.  Whether or not they will approve it or not, would also depend on the safety.  In my view you have a much higher likelihood at that point.
Still, its a long road ahead, and looking at the finances on the recent reports, you can judge how likely that is.
 
  "Also - Won't the real life results of patients getting better in Canada help support the submission?"
 
In my view, almost certainly  not.
 
I have seen many posers here  over the last year talk about videos and testimonials, and these are not considered strong evidence, and in many cases not even considered.

Again, my view only-all of the above, and dont invest or not based on my views.

 
Read more at https://stockhouse.com/companies/bullboard?symbol=hsdt&postid=30415852#gYdmq1tz0RLomcos.99
Bullboard Posts